xRead - Nasal Obstruction (September 2024) Full Articles

20426984, 2021, 3, Downloaded from https://onlinelibrary.wiley.com/doi/10.1002/alr.22741 by Stanford University, Wiley Online Library on [01/07/2024]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License

241

Orlandi et al.

II.A. List of Abbreviations Used 3D-CTA three-dimensional computed tomography angiography AAOA American Academy of Otolaryngic Allergy AAO-HNS American Academy of Otolaryngology - Head and Neck Surgery AAP American Academy of Pediatrics ABRS acute bacterial rhinosinusitis ACE2 angiotensin-converting enzyme 2 AcRh acoustic rhinometry ACT Asthma Control Test ACTH adrenocorticotropic hormone AD aspirin desensitization AE adverse event AECRS acute exacerbation of chronic rhinosinusi tis AERD aspirin exacerbated respiratory disease AFRS allergic fungal rhinosinusitis AGP aerosol generating procedure AHLs acyl-homoserine lactones AIFS acute invasive fungal rhinosinusitis AJC apical junction complex α -SMA alpha smooth muscle actin AMA-PCPI American Medical Association Physician Consortium for Practice Improvement AMCase acidic mammalian chitinase AMT appropriate medical therapy APDS activated phosphoinositide 3-kinase delta syndrome AOAH acyloxyacyl hydroxylase AQLQ Asthma Quality of Life Questionnaire AR allergic rhinitis ATP adenosine triphosphate AVRS acute viral rhinosinusitis BC black carbon BCD balloon catheter dilation bFGF basic fibroblast growth factor BID twice daily BMP bone morphogenetic protein BSACI British Society of Allergy and Clinical Immunology C3 complement component 3 CAg colloidal silver ARS acute rhinosinusitis ASA acetyl salacylic acid ASL airway surface layer ATA asthma tolerant to anti-inflammatory drugs

CCL1 chemokine (C-C motif) ligand 1 CD chitosan-dextran CF cystic fibrosis CFTR cystic fibrosis transmembrane conduc tance regulator CGD chronic granulomatous disease CI confidence interval CIFS chronic invasive fungal rhinosinusitis CMC carboxymethylcellulose CMS Centers for Medicare & Medicaid Services CoV coronavirus COX cyclo-oxygenase CPODS facial congestion/fullness, facial pain/ pressure, nasal obstruction/blockage, nasal drainage, and smell dysfunction CRP C-reactive protein CRS chronic rhinosinusitis CRSsNP chronic rhinosinusitis without nasal polyps CRSwNP chronic rhinosinusitis with nasal polyps CS conventional septoplasty CSF cerebrospinal fluid CSS Chronic Sinusitis Survey CT computerized tomography CVID common variable immunodeficiency CYP27B1 cytochrome P450 family 27 subfamily B member 1 cysLT cysteinyl leukotriene DB double blind DBRCT double blind randomized controlled trial DEX dexmedetomidine DM diabetes mellitus DNA deoxyribonucleic acid DTH delayed-type hypersensitivity EBL estimated blood loss EBM evidence-based medicine EBR evidence-based review EBRR evidence-based review with recommenda tions ECP eosinophilic cationic protein EDN eosinophil derived neurotoxin EDS-FLU exhalation delivery system with fluticas one EGF epidermal growth factor EGPA eosinophilic granulomatosis with polyangiitis ELISA enzyme-linked immunosorbent assay

CBC complete blood count CBF ciliary beat frequency CCAD central compartment atopic disease